180 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
attention;
withdrawal of clinical trial participants;
significant costs to defend resulting litigation;
substantial monetary awards to trial … . The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial. We would need to increase our
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
;
withdrawal of clinical trial participants;
significant costs to defend resulting litigation;
substantial monetary awards to trial participants or patients … liability litigation or other proceeding, even if resolved in our favor, could be substantial. We would need to increase our insurance coverage
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
litigation;
substantial monetary awards to trial participants or patients;
loss of revenue;
reduced resources of our management to pursue our business … not fully cover potential liabilities that we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor
8-K
EX-10.2
z571meal2krrkt0
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
30ldxglnxn1x3p9 udr
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
r9y44eygi6idq2jn
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.2
46be 36fv6
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
424B4
prim8qxq0y467dh2v
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
sge 2d47pc7ta1t
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
dub8jqx lwhyfp
17 Nov 23
Prospectus supplement
5:00pm
424B4
7xdaxunfx43b9rye4
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B3
cqragf9rz m5ovm0gdk
17 Aug 23
Prospectus supplement
5:00pm